EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling. [electronic resource]
Producer: 20090313Description: 528-37 p. digitalISSN:- 1097-0045
- Adenocarcinoma -- metabolism
- Bone Neoplasms -- metabolism
- Bone Remodeling -- drug effects
- Cell Line, Tumor
- Disease Progression
- Epidermal Growth Factor -- pharmacology
- ErbB Receptors -- metabolism
- Humans
- Ligands
- Male
- Mitogen-Activated Protein Kinase Kinases -- metabolism
- Models, Biological
- Neoplasm Staging
- Prostatic Neoplasms -- metabolism
- Proto-Oncogene Proteins c-akt -- metabolism
- RANK Ligand
- Signal Transduction -- drug effects
- Transforming Growth Factor alpha -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.